The use of lymphocytes to screen for oxidative phosphorylation disorders

Analytical Biochemistry

Volumn 313, Issue 1, 2003, Pages 137-144

  Marriage, Barbara J ^a   Clandinin, M Thomas ^a   MacDonald, Ian M ^a   Glerum, D Moira ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ATP; Lymphocytes; Mitochondrial; Oxidative phosphorylation

Indexed keywords

ADENOSINETRIPHOSPHATE; DIAGNOSIS; FIBROBLASTS; MITOCHONDRIA; PHOSPHORYLATION; TISSUE CULTURE;

BIOCHEMICAL ANALYSIS; CELL TRANSFORMATION; DIAGNOSTIC PROCEDURE; MITOCHONDRIAL; MITOCHONDRIAL ACTIVITY; OXIDATIVE PHOSPHORYLATION; REPEATED MEASUREMENTS; SCREENING TECHNIQUES;

LYMPHOCYTES;

ADENOSINE TRIPHOSPHATE;

ADULT; ARTICLE; BLOOD SAMPLING; CELL INTERACTION; CELL LINE; CELL TRANSFORMATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; LYMPHOBLAST; LYMPHOCYTE; MALE; MEASUREMENT; METHODOLOGY; MITOCHONDRIAL RESPIRATION; NON INVASIVE MEASUREMENT; OXIDATIVE PHOSPHORYLATION; PATIENT MONITORING; PRIORITY JOURNAL; REPRODUCIBILITY; SCHOOL CHILD; SCREENING TEST; SKIN FIBROBLAST; SYNTHESIS; TIME;

EID: 0037328533     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(02)00539-0     Document Type: Article

References (55)

1. Munnich A., Rustin P. Clinical spectrum and diagnosis of mitochondrial disorders. Am. J. Med. Genet. 106:2001;4-17.
2. Munnich A., Rotig A., Chretien D., Saudubray J.M., Cormier V., Rustin P. Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur. J. Pediatr. 155:1996;262-274.
3. Shoubridge E.A. Nuclear genetic defects of oxidative phosphorylation. Hum. Mol. Genet. 10:2001;2277-2284.
4. Robinson B. The metabolic and molecular bases of inherited disease. vol. 2:2001;2275-2295 McGraw-Hill, New York.
5. Jackson M.J., Schaefer J.A., Johnson M.A., Morris A.A., Turnbull D.M., Bindoff L.A. Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain. 118:1995;339-357.
6. Robinson B.H. Use of fibroblast and lymphoblast cultures for detection of respiratory chain defects. Methods Enzymol. 264:1996;454-464.
7. Bourgeron T., Chretien D., Rotig A., Munnich A., Rustin P. Isolation and characterization of mitochondria from human B lymphoblastoid cell lines. Biochem. Biophys. Res. Commun. 186:1992;16-23.
8. Wanders R.J., Ruiter J.P., Wijburg F.A. Studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts: application to mitochondrial encephalomyopathies. Biochim. Biophys. Acta. 1181:1993;219-222.
9. Fotino M., Merson E.J., Allen F.H. Jr. Micromethod for rapid separation of lymphocytes from peripheral blood. Ann. Clin. Lab Sci. 1:1971;131-133.
10. Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
11. Williamson J.R., Safer B., LaNoue K.F., Smith C.M., Walajtys E. Mitochondrial-cytosolic interactions in cardiac tissue: role of the malate-aspartate cycle in the removal of glycolytic NADH from the cytosol. Symp. Soc. Exp. Biol. 27:1973;241-281.
12. Trounce I.A., Kim Y.L., Jun A.S., Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 264:1996;484-509.
13. Robinson B.H., Ward J., Goodyer P., Baudet A. Respiratory chain defects in the mitochondria of cultured skin fibroblasts from three patients with lacticacidemia. J. Clin. Invest. 77:1986;1422-1427.
14. Rustin P., Lebidois J., Chretien D., Bourgeron T., Piechaud J.F., Rotig A., Sidi D., Munnich A. The investigation of respiratory chain disorders in heart using endomyocardial biopsies. J. Inherit. Metab. Dis. 16:1993;541-544.
15. Kirby D.M., Crawford M., Cleary M.A., Dahl H.H., Dennett X., Thorburn D.R. Respiratory chain complex I deficiency: an underdiagnosed energy generation disorder. Neurology. 52:1999;1255-1264.
16. Davey G.P., Peuchen S., Clark J.B. Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J. Biol. Chem. 273:1998;12753-12757.
17. Davey G.P., Clark J.B. Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J. Neurochem. 66:1996;1617-1624.
18. Wallace D.C., Lott M.T., Brown G.K., Kerstann K. The Metabolic and Molecular Bases of Inherited Disease. vol. 2:2001;2425-2509 McGraw-Hill, New York.
19. Olsen N.K., Hansen A.W., Norby S., Edal A.L., Jorgensen J.R., Rosenberg T. Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation. Acta Neurol. Scand. 91:1995;326-329.
20. Nikoskelainen E.K., Marttila R.J., Huoponen K., Juvonen V., Lamminen T., Sonninen P., Savontaus M.L. Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. J. Neurol. Neurosurg. Psychiatry. 59:1995;160-164.
21. Majander A., Huoponen K., Savontaus M.L., Nikoskelainen E., Wikstrom M. Electron transfer properties of NADH:ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON). FEBS Lett. 292:1991;289-292.
22. Larsson N.G., Andersen O., Holme E., Oldfors A., Wahlstrom J. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann. Neurol. 30:1991;701-708.
23. Degli Esposti M., Carelli V., Ghelli A., Ratta M., Crimi M., Sangiorgi S., Montagna P., Lenaz G., Lugaresi E., Cortelli P. Functional alterations of the mitochondrially encoded ND4 subunit associated with Leber's hereditary optic neuropathy. FEBS Lett. 352:1994;375-379.
24. Carelli V., Ghelli A., Ratta M., Bacchilega E., Sangiorgi S., Mancini R., Leuzzi V., Cortelli P., Montagna P., Lugaresi E., Degli Esposti M. Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology. 48:1997;1623-1632.
25. Smith P.R., Cooper J.M., Govan G.G., Harding A.E., Schapira A.H. Platelet mitochondrial function in Leber's hereditary optic neuropathy. J. Neurol. Sci. 122:1994;80-83.
26. Majander A., Finel M., Savontaus M.L., Nikoskelainen E., Wikstrom M. Catalytic activity of complex I in cell lines that possess replacement mutations in the ND genes in Leber's hereditary optic neuropathy. Eur. J. Biochem. 239:1996;201-207.
27. King M.P., Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science. 246:1989;500-503.
28. Ciafaloni E., Ricci E., Shanske S., Moraes C.T., Silvestri G., Hirano M., Simonetti S., Angelini C., Donati M.A., Garcia C.et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann. Neurol. 31:1992;391-398.
29. Goto Y., Nonaka I., Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim. Biophys. Acta. 1097:1991;238-240.
30. Enter C., Muller-Hocker J., Zierz S., Kurlemann G., Pongratz D., Forster C., Obermaier-Kusser B., Gerbitz K.D. A specific point mutation in the mitochondrial genome of Caucasians with MELAS. Hum. Genet. 88:1991;233-236.
31. Kobayashi Y., Momoi M.Y., Tominaga K., Momoi T., Nihei K., Yanagisawa M., Kagawa Y., Ohta S. A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem. Biophys. Res. Commun. 173:1990;816-822.
32. Goto Y., Tojo M., Tohyama J., Horai S., Nonaka I. A novel point mutation in the mitochondrial tRNA(Leu)(UUR) gene in a family with mitochondrial myopathy. Ann. Neurol. 31:1992;672-675.
33. Morgan-Hughes J.A., Sweeney M.G., Cooper J.M., Hammans S.R., Brockington M., Schapira A.H., Harding A.E., Clark J.B. Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype. Biochim. Biophys. Acta. 1271:1995;135-140.
34. Koo B., Becker L.E., Chuang S., Merante F., Robinson B.H., MacGregor D., Tein I., Ho V.B., McGreal D.A., Wherrett J.R.et al. Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): clinical, radiological, pathological, and genetic observations. Ann. Neurol. 34:1993;25-32.
35. Shoffner J.M. The Metabolic and Molecular Bases of Inherited Disease. vol. 2:2001;2367-2423 McGraw-Hill, New York.
36. Kunz D., Luley C., Fritz S., Bohnensack R., Winkler K., Kunz W.S., Wallesch C.W. Oxygraphic evaluation of mitochondrial function in digitonin-permeabilized mononuclear cells and cultured skin fibroblasts of patients with chronic progressive external ophthalmoplegia. Biochem. Mol. Med. 54:1995;105-111.
37. Hirano M., Marti R., Ferreiro-Barros C., Vila M.R., Tadesse S., Nishigaki Y., Nishino I., Vu T.H. Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin. Cell. Dev. Biol. 12:2001;417-427.
38. Ponamarev M.V., Longley M.J., Nguyen D., Kunkel T.A., Copeland W.C. Active site mutation in DNA polymerase gamma associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. J. Biol. Chem. 277:2002;15225-15228.
39. Van Goethem G., Dermaut B., Lofgren A., Martin J.J., Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat. Genet. 28:2001;211-212.
40. Zeviani M., Servidei S., Gellera C., Bertini E., DiMauro S., DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature. 339:1989;309-311.
41. Wang H., Oster G. Energy transduction in the F1 motor of ATP synthase. Nature. 396:1998;279-282.
42. Makela-Bengs P., Suomalainen A., Majander A., Rapola J., Kalimo H., Nuutila A., Pihko H. Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome. Pediatr. Res. 37:1995;634-639.
43. Tatuch Y., Robinson B.H. The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem. Biophys. Res. Commun. 192:1993;124-128.
44. Shoubridge E.A. Cytochrome c oxidase deficiency. Am. J. Med. Genet. 106:2001;46-52.
45. Robinson B.H., McKay N., Goodyer P., Lancaster G. Defective intramitochondrial NADH oxidation in skin fibroblasts from an infant with fatal neonatal lacticacidemia. Am. J. Hum. Genet. 37:1985;938-946.
46. Abe K., Fujimura H., Nishikawa Y., Yorifuji S., Mezaki T., Hirono N., Nishitani N., Kameyama M. Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta. Neurol. Scand. 83:1991;356-359.
47. Rustin P., Chretien D., Bourgeron T., Gerard B., Rotig A., Saudubray J.M., Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta. 228:1994;35-51.
48. Taylor D.J., Turnbull D.M. Applegarth D.A., Dimmick J.E., Hall J.G. Organelle Diseases. 1997;341-350 Chapman & Hall, New York.
49. Robinson B.H. Lacticacidemia. Biochim. Biophys. Acta. 1182:1993;231-244.
50. Bourgeron T., Chretien D., Rotig A., Munnich A., Rustin P. Fate and expression of the deleted mitochondrial DNA differ between human heteroplasmic skin fibroblast and Epstein-Barr virus-transformed lymphocyte cultures. J. Biol. Chem. 268:1993;19369-19376.
51. Torroni A., Stepien G., Hodge J.A., Wallace D.C. Neoplastic transformation is associated with coordinate induction of nuclear and cytoplasmic oxidative phosphorylation genes. J. Biol. Chem. 265:1990;20589-20593.
52. Kinchington D., Griffin B.E. Size heterogeneity of EBV and mitochondrial DNAs in Burkitt's lymphoma lines. Nucleic Acids Res. 15:1987;10345-10354.
53. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65:1991;1107-1115.
54. Tyller D. The Mitochondrion in Health and Disease. 1992;VCH, New York.
55. Chinnery P.F., Howell N., Andrews R.M., Turnbull D.M. Clinical mitochondrial genetics. J. Med. Genet. 36:1999;425-436.